Cargando…
Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting
BACKGROUND: Given the high prevalence of cognitive impairment in Parkinson’s disease (PD), cognitive screening is important in clinical practice. The Montreal Cognitive Assessment (MoCA) is a frequently used screening test in PD to detect mild cognitive impairment (PD-MCI) and Parkinson’s disease de...
Autores principales: | Fengler, Sophie, Kessler, Josef, Timmermann, Lars, Zapf, Alexandra, Elben, Saskia, Wojtecki, Lars, Tucha, Oliver, Kalbe, Elke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954721/ https://www.ncbi.nlm.nih.gov/pubmed/27437705 http://dx.doi.org/10.1371/journal.pone.0159318 |
Ejemplares similares
-
Effects of Sociodemographic Variables and Depressive Symptoms on MoCA Test Performance in Native Germans and Turkish Migrants in Germany
por: Anapa, Görkem, et al.
Publicado: (2021) -
Norms and equivalences for MoCA-30, MoCA-22, and MMSE in the oldest-old
por: Melikyan, Zarui A., et al.
Publicado: (2021) -
Conversion of MoCA to MMSE scores
por: Falkowski, Jed A., et al.
Publicado: (2015) -
Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients()()
por: Xu, Yaqian, et al.
Publicado: (2020) -
Resting state EEG as biomarker of cognitive training and physical activity’s joint effect in Parkinson’s patients with mild cognitive impairment
por: Trenado, Carlos, et al.
Publicado: (2023)